ARTICLE | Clinical News
Xechem preclinical data
March 1, 2004 8:00 AM UTC
XKEM subsidiary CepTor Corp. (Stony Brook, N.Y.) reported that Neurodur reduced clinical signs and increased survival in a mouse model of MS. XKEM said it would file an IND for Neurodur to treat MS b...